Iovance Biotherapeutics (IOVA): next trial readout expected around 2028-03-01
$IOVA · Iovance Biotherapeutics, Inc.Trials that could report in the next 12 months: 2BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything IOVA is running — see methodology.
- 2028-03-01in 80wStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- 2033-09-01in 367wA Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With … | Phase 2 | Not Yet Recruitingnot open yet | 2033-09-01 | NCT07741877 |
| Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared Wi… | Phase 3 | Recruitingstill enrolling patients | 2028-03-01 | NCT05727904 |
| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4… | Phase 1 | Recruitingstill enrolling patients | NCT05361174 | |
| A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults W… | Phase 1 | Recruitingstill enrolling patients | NCT06940739 | |
| A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With … | Phase 2 | Active Not Recruitingenrolled, still running | NCT07288203 | |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Canc… | Phase 2 | Recruitingstill enrolling patients | NCT04614103 | |
| A Study of IOV-5001 in Adults With Advanced Solid Tumors | Phase 1 | Not Yet Recruitingnot open yet | NCT07743723 | |
| A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With … | Phase 2 | Recruitingstill enrolling patients | NCT06481592 |
Status-change history
Every ClinicalTrials.gov change recorded for IOVA's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is IOVA's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is IOVA's lead program in?
Phase 3 — recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.